The purpose of this study is to evaluate the use and functionality of virtual reality (VR) during radiation therapy treatments for patients with prostate, breast, lung, or head and neck cancer.
This is a randomized controlled trial that will assess the feasibility, acceptability, tolerability, and initial clinical efficacy of using a VR device during radiation therapy for participants with prostate cancer, breast cancer, lung cancer, or head and neck cancer. Participants will be randomized 2:1 to either the VR device intervention arm or the standard of care control arm. Participants will undergo pre-study assessments, assessments before and after the first radiation treatment, every 6th radiation treatment, and at the end of treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
54
Radiation therapy for prostate cancer, breast cancer, lung cancer, or head and neck cancer.
Participants will wear the VR headset (Meta Quest 2) during standard of care radiation therapy
Radiation therapists will be asked about their experiences and proficiency with using the VR device.
Atrium Health Wake Forest Baptist Hayworth Cancer Center
High Point, North Carolina, United States
RECRUITINGVR Use During Treatment
A binary variable (Yes/No) will be created for participants at the level of individual treatment visit to signify whether the participants wore the VR device for the duration of their treatment.
Time frame: Periprocedural (each treatment visit)
VR Functionality
VR device functionality (0-2) will be determined at the level of individual treatment visit using the following criteria as determined by the participant and/or treatment staff: 0 = device not functional at any time during the treatment 1. = device functional for part but not all of the treatment duration 2. = device was functional for the duration of the treatment
Time frame: Periprocedural (each treatment visit)
Anxiety - Change over time
Generalized Anxiety Disorder 7-item (GAD-7) to assess pre-existing generalized anxiety and the 23-item Radiotherapy Experience Questionnaire (RTEQ) situational unease and situational repose subscales.
Time frame: GAD-7: Baseline RTEQ: Periprocedural (After first and last treatment)
Acceptability of Implementing VR
Radiation Therapist Survey (Administered to staff only)
Time frame: At 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.